The individual deals have been landing all week — a $30 billion chip commitment, a $10 billion drug buyout, a £12.6 billion run at Europe’s biggest warehouse landlord. Step back and they resolve into one picture: 2026 is on track to be the biggest year for mergers and acquisitions on record. Companies announced roughly $2.8 trillion of deals in the first six months, up 48% from a year earlier and the busiest first half since LSEG’s data begins in 1980. Morgan Stanley now expects the full year to clear about $6.4 trillion — enough to eclipse the 2021 boom almost everyone assumed was a once-a-cycle peak.
The strange part is that dealmakers got less busy by one measure and far busier by another. The number of transactions fell about 9%, to roughly 24,000 — the lowest first-half count in six years. What exploded was size. Some 47 deals worth more than $10 billion apiece were announced in the half, together topping $1.3 trillion, or nearly half of all deal value. This is not a broad, democratic return of dealmaking. It is a handful of giants making enormous, transformative bets while much of the mid-market sits on its hands.
Three forces are fueling it. Technology is the single largest sector at about $649 billion, as the AI arms race pushes incumbents to buy capability rather than build it. Cross-border activity roared back to roughly $893 billion, up 62% and the strongest start since 2018. And the money is cheap and available: investment-grade companies issued a record $3.4 trillion of debt in the half, up 10%, handing acquirers a full tank for the next big swing.
Our take: The story isn’t “M&A is back.” It’s that scale is eating the market. When deal value sets a record while deal count sinks to a six-year low, the action has concentrated at the very top — a small club of cash-rich, stock-rich giants reshaping whole industries in single strokes while everyone below them waits. That’s why your feed keeps filling with ten-figure takeovers: they aren’t isolated headlines, they’re the visible peaks of a consolidation wave. If you compete against, supply, or work for the companies in these sectors, the question of 2026 isn’t whether consolidation reaches you. It’s whether you end up owning, owned, or squeezed in the middle.
You’ve seen the pattern in the deals we’ve tracked: Apple committing more than $30 billion to U.S.-made chips and Prologis taking a £12.6 billion warehouse bid straight to shareholders, alongside drug and auto-parts giants stacking their own $10 billion offers. Each looked like a one-off. Together they’re a supercycle — and the survey data driving the optimism carries its own warning: dealmakers rank legal and regulatory hurdles as their top obstacle, the reason a deal like Getty’s $3.7 billion Shutterstock merger can die on a single regulator’s desk.
What to watch
- Whether the pace holds. A dealmaker sentiment survey found more than half expect activity to accelerate in the second half, and 43% expect to work on four or more deals. But Q2’s 64% year-over-year surge in announced deals sets a bar that’s easy to miss.
- The regulators. Antitrust and national-security reviews are the biggest thing standing between announced and completed. Mega-deals draw mega-scrutiny.
- Financing costs. The record debt issuance funding this ran on cheap money. If rates or credit spreads move, the biggest bets get expensive fast.
- The middle. Deal count is at a six-year low. A thaw in mid-market M&A would be the signal that confidence has finally broadened beyond the giants.